Updated requirements for Medication Compounding align with USP revisions

To align with the U.S. Pharmacopeia (USP) revisions for medication compounding released in November 2022, The Joint Commission has revised its Medication Compounding (MC) chapter for home care organizations and the Medication Compounding Certification (MDC) program, which is available to Joint Commission-accredited hospitals, critical access hospitals, and home care pharmacy organizations. The revisions go into effect on Jan. 1, 2024.

The Joint Commission undertook a thorough analysis of the USP revisions and rewrote the MC and MDC requirements, resulting in the following:

• Revisions to the requirements to align with the updated USP requirements.
• Reorganization of the requirements.
• Renumbering of the standards.
• Reducing the number of elements of performance (EPs) in MC by 58% and MDC by 72%.

The revisions relate to general responsibilities, staff competency, the compounding environment, compounding operations, sterile and nonsterile compounding, and nuclear pharmacy.

View the prepublication standards.